NATIONAL PHARMACEUTICAL PRICING में लूट
National Pharmaceutical Pricing Authority , Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals and the Great Indian Courts part of Great Ramon Circus each ignoring its duty right up to…
GLIPTIN FAMILY LAUNCHED BY MANKIND
NEW DELHI: Mankind Pharma has launched an anti-diabetic product ‘Dynaglipt’ targeting the middle class and rural diabetic patients. The company has launched an affordable anti-diabetic product for the diabetic patients…
EASE OF DOING NEW DRUG APPROVAL BY CDSCO
New Delhi: Narendra Modi, PM of India had given directive to all ministries just after joining the post to follow “ease of business” means fast clearance from government offices. PM…
PHASE IV CLINICAL TRIAL IS HARD NUT TO CRACK FOR INDUSTRY
New Delhi: In the month of July, Joint DCGI has issued letter to most of the FDC applicant (FDC already approved by state licensing authority) to submit protocol for Phase…
Paradigm Shift in Indian nutraceuticals market by 2020: Study
NEW DELHI: Indian nutraceuticals market is set to grow over two-fold to $6.1 billion by 2020 as consumers become more conscious towards health and fitness, according to a study. The…
Generic vs Branded
New Delhi, The ‘branded’ argument easily scores a very strong point of quality in ‘generics versus branded medicine’ debate, ever after mass women death at a sterilization camp in Chhattisgarh…
